EPFL team unveils unified 3D generative model for structure-based drug design and docking

HannesStaerk · x · 2026-11-20

Researchers from EPFL (Igashov, Schneuing, Correia, with Bronstein and Schwaller among co-authors) released a bioRxiv preprint on a unified 3D generative model for synthesizable structure-based drug design. Using BRICS fragmentation plus masked modeling on protein-ligand complexes, one model handles de novo design, docking, joint design+docking, fragment-based design, and constrained docking — controlling flexibly which atoms, bonds, or 3D coordinates are generated. The team presented it on the Starkly Speaking Zoom seminar.

Original post →

More from Embodied

Embodied channel →